Triamcinolone Acetonide 40 MG/ML Injectable Suspension [Kenalog]

Known as: TRIAMCINOLONE ACETONIDE 40 mg in 1 mL INTRA-ARTICULAR INJECTION, SUSPENSION [Kenalog 40], Kenalog 40 MG/ML Injectable Suspension, Kenalog-40 40 MG/ML Injectable Suspension 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1982-2013
0119822013

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
PURPOSE To assess the natural course of the mild diabetic macular edema(DME) and to compare the visual outcomes with the patients… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2010
2010
OBJECTIVE To investigate the relationship between inhibitory effect of triamcinolone acetonide(TA) on hypertrophic scar and… (More)
Is this relevant?
2009
2009
PURPOSE To determine vitreous concentrations of triamcinolone acetonide(TA) following transseptal injection. METHODS TA (40 mg… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2006
2006
PURPOSE To evaluate the clinical effect of 5-microm pore filter connected with three-way cock by removing the vehicle in… (More)
Is this relevant?
2004
2004
PURPOSE To report the efficacy of intravitreal injection of triamcinolone acetonide(TA) for cystoid macular edema remaining after… (More)
Is this relevant?
1993
1993
Triamcinolone acetonide-21-palmitate was synthesized and incorporated into liposomes for intra-articular treatment of an… (More)
Is this relevant?